Page last updated: 2024-08-25

squalamine and Branch Vein Occlusion

squalamine has been researched along with Branch Vein Occlusion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, AY; Wroblewski, JJ1
Blake, DA; Farahat, HG; Genaidy, M; Holroyd, KJ; Kazi, AA; Passos-Machado, E; Peyman, GA; Williams, JI1

Trials

1 trial(s) available for squalamine and Branch Vein Occlusion

ArticleYear
Topical Squalamine 0.2% and Intravitreal Ranibizumab 0.5 mg as Combination Therapy for Macular Edema Due to Branch and Central Retinal Vein Occlusion: An Open-Label, Randomized Study.
    Ophthalmic surgery, lasers & imaging retina, 2016, Oct-01, Volume: 47, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Cholestanols; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ranibizumab; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity

2016

Other Studies

1 other study(ies) available for squalamine and Branch Vein Occlusion

ArticleYear
Effect of squalamine on iris neovascularization in monkeys.
    Retina (Philadelphia, Pa.), 2002, Volume: 22, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Cholestanols; Disease Models, Animal; Fluorescein Angiography; Infusions, Intravenous; Injections; Iris; Laser Coagulation; Macaca fascicularis; Neovascularization, Pathologic; Retinal Vein; Retinal Vein Occlusion; Vitreous Body

2002